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Abstract
Background: Close to 800 million people in the world are at risk of schistosomiasis, 85 per cent of whom live in Africa.
Recent studies have indicated that female genital schistosomiasis might increase the risk of human immunodeficiency virus
(HIV) infection. The aim of this study is to quantify and analyse the characteristics of the vasculature surrounding
Schistosoma haematobium ova in the female genital mucosa.
Methodology/Principal Findings: Cervicovaginal biopsies with S. haematobium ova (n = 20) and control biopsies (n = 69)
were stained with immunohistochemical blood vessel markers CD31 and von Willebrand Factor (vWF), which stain
endothelial cells in capillary buds and established blood vessels respectively. Haematoxylin and eosin (HE) were applied for
histopathological assessment. The tissue surrounding S. haematobium ova had a higher density of established blood vessels
stained by vWF compared to healthy controls (p= 0.017). Immunostain to CD31 identified significantly more granulation
tissue surrounding viable compared to calcified ova (p= 0.032), and a tendency to neovascularisation in the tissue
surrounding viable ova compared to healthy cervical mucosa (p= 0.052).
Conclusions/Significance: In this study female genital mucosa with S. haematobium ova was significantly more vascularised
compared to healthy cervical tissue. Viable parasite ova were associated with granulation tissue rich in sprouting blood
vessels. Although the findings of blood vessel proliferation in this study may be a step to better understand the implications
of S. haematobium infection, further studies are needed to explore the biological, clinical and epidemiological features of
female genital schistosomiasis and its possible influence on HIV susceptibility.
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Introduction
Schistosomiasis is the most important parasite infection in the
world after malaria [1]. Of the estimated 780 million people
exposed to this fresh water parasite, 85 per cent live in Africa.
Schistosoma haematobium and human immunodeficiency virus (HIV)
are co-endemic in large parts of this area [2,3]. In a recent cross-
sectional study from Zimbabwe a near 3-fold increased odds for
HIV infection was found in women with genital schistosomiasis
[4].
The lower female reproductive tract is a major entry site in HIV
transmission, and is also a common site for S. haematobium
oviposition [5–7]. The S. haematobium infected cervix appears
inflamed with abnormal mucosal blood vessels, contact bleeding
and pathognomonic lesions named sandy patches [7–9]. It has
been suggested that products from schistosome ova (S. mansoni)
may induce endothelial cell proliferation and activation [10,11].
Similar to sexually transmitted infections, it has been postulated
that female genital schistosomiasis may provide mucosal points of
entry for HIV [12,13].
The aim of this study is to combine immunohistochemical
protein detection of endothelial cells with histopathological
evaluation to quantify and analyse the characteristics of the blood




Permissions for the histopathological and immunohistochemical
investigations of anonymised archival Malawian and Norwegian
biopsies, without additional consent from the study subjects, were
granted by the National Health Science and Research Committee
of Malawi (2009/NHSRC #620) and the Norwegian Regional
Ethics Committee (2009/1250a). The permissions were based on
the fact that the proposed analyses did not require identifiable
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information or history, have any direct relevance to the physical,
mental or social well-being, or have any direct diagnostic or
therapeutic implications for the study women.
The majority of the Malawian women who volunteered in the
1994 study were illiterate [8]. Study information was provided in
Yao and Chichewa (the local languages) and free informed oral
consent was obtained. Following consent, all women who had
urinary schistosomiasis were offered gynaecological examination.
Consent was reascertained orally by the physician before each step
of sampling and investigations. Treatment and follow-up for
sexually transmitted infections, cancers and other complaints were
done in collaboration with the physicians in Mangochi District
Hospital [8]. The women were not asked for HIV testing. All
women, including those who declined further investigations, were
offered treatment with praziquantel. All non-endemic controls
were followed up by the referring clinician in Norway.
Study subjects
As described previously [8], biopsies from the cervix and/or
vagina were sampled from 61 women with urogenital S.
haematobium infection in Mangochi District Hospital in Malawi in
1994. In short, sexually active women between 15 and 49 years of
age present in the out-patient department, irrespective of whether
they were patients or next of kin, were invited to submit urine
samples. Women with S. haematobium ova in the urine were invited
for further interviews and gynaecological examinations. Samples
including biopsies were taken from observed lesions or at random
if no lesions were present. Women without urinary schistosomiasis
were excluded.
An overview of the study groups is given in Figure 1. The cases
with S. haematobium ova in genital tissue included 17 cervical and
three vaginal biopsies. The histopathological changes and ova
viability were similar in the cervical and vaginal biopsies, and the
biopsies were therefore analysed together. Malawian women with
urinary schistosomiasis who were found not to have S. haematobium
ova in the biopsy specimen served as endemic negative controls.
Non-endemic Norwegian control biopsies were selected by
searching the database from 1998 for key word combinations of
the anatomical site ‘cervix uteri’ and the morphological diagnoses
‘cervicitis’ and ‘normal morphology’. Women included in the
negative non-endemic control group had histologically normal
uterine ectocervices with intact tissue architecture. Excluded were
endocervical biopsies and biopsies showing signs of pathology, i.e.
more than 10 inflammatory cells per high-power field, non-specific
vessel proliferation, epithelial hyperplasia, polyps, cysts, atypical or
dysplastic changes, or signs of human papilloma virus (HPV)
infection (i.e. clustered koilocytosis and dyskeratosis).
Women included in the positive non-endemic control group had
chronic non-specific cervicitis; i.e. biopsies with a distinct,
generalised infiltrate dominated by lymphocytes and/or plasma
cells. Excluded were endocervical biopsies with more than 20
granulocytes or 5 eosinophils per high-power field and specimens
with signs of HPV infection, erosion, ulcerations, granulation
tissue or extra-vascular erythrocytes.
Immunohistochemistry and histopathology
The biopsies were fixed in formalin, routinely processed,
embedded in paraffin, sectioned and stained. Findings from the
histological examination of haematoxylin and eosin (HE)-stained
sections have been published previously [14].
For the analyses in this study, 3.5 mm thick serial sections of the
included specimens were cut and placed on SuperFrost slides
(Menzel-Gla¨ser, Braunschweig, Germany) for HE-stain and on
SuperFrost Plus slides (Menzel-Gla¨ser) for immunohistochemical
stains. The immunohistochemical stains were performed using
Benchmark XT, Antibody diluent (251-018) and Detection Kit
Ventana ultraView Universal DAB (760-500) (Ventana Medical
Systems, Inc., Tucson, Arizona, USA), an automated immuno-
stain system based on the ABC avidin-biotin-peroxidase method,
including negative and positive controls. For identification of
blood vessels, two endothelial cell markers were used; mouse
monoclonal antibody CD31 (clone JC70A, Dako Denmark AS,
Glostrup, Denmark) and rabbit polyclonal antibody von Will-
ebrand Factor (vWF) (Ventana). All slides were examined
microscopically for immunohistochemical antigen detection com-
bined with histological identification.
Microscopy and image analysis
The sections were examined using a Nikon Eclipse 80i
microscope and photographed at 406 objective magnification,
obtaining 1600 by 1200 pixels colour images using a SPOT Insight
2 Megapixel Firewire Color 3-shot digital camera attached to the
microscope and a Hewlett-Packard Compaq stationary computer.
The morphological and immunohistochemical analyses were
performed in a standardised manner. First, the HE-stained
sections were evaluated. Ova were defined as ‘viable’ if miracidia
with eosinophilic glands or germinal cells were identified [15],
whereas ova containing dark purple stain identified histologically
as calcification were defined as ‘calcified’. The histopathological
tissue reaction was defined as ‘granulation tissue’ if dominated by
neovascularisation with activation of endothelial cells and by
immature fibroblasts. The tissue reaction was defined as ‘fibrosis’ if
dominated by collagen rich stroma with scant mature fibroblasts.
A high-power field (406 objective magnification) of each HE-
stained section containing S. haematobium ova was photographed
with the ovum or ova located centrally. The area of tissue
surrounding the ovum or ova in one such photograph was defined
as ‘periovular’. In the controls, one high-power field of a
subepithelial area was photographed, as this is the most common
location for oviposition [15,16]. This area was representative for
the pathologist’s overall diagnosis of the section. In order to
analyse the same area in the consecutive immunohistochemically
stained serial sections of each biopsy, the near-exact same areas,
Author Summary
Schistosomiasis is a fresh water parasite infection that
affects millions of people, especially in Africa. Recent
knowledge about the genital manifestations of schistoso-
miasis; especially its possible association with human
immunodeficiency virus (HIV) infection, has led to
increased focus on this neglected tropical disease. Millions
of women remain undiagnosed for genital schistosomiasis,
and may suffer from abnormal mucosal blood vessels,
contact bleeding and lesions named sandy patches. This
study analyses a unique selection of female genital
biopsies containing parasite eggs. Protein detection and
standard histopathological assessment are combined to
quantify and study the characteristics of the mucosal
blood vessels surrounding the eggs. Our results show that
the genital mucosa with parasite eggs is more vascularised
compared to healthy tissue, and that viable eggs tend to
be surrounded by proliferating blood vessels. These
findings have not yet been correlated directly to clinical
manifestations. Further studies are needed in order to
provide clinical advice on the risks and consequences of
mucosal lesions particular to female genital schistosomi-
asis.
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Figure 1. Overview of the study groups.
doi:10.1371/journal.pntd.0001170.g001
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identified by histological anatomical structures, were photo-
graphed. In areas where the morphology of the immunohisto-
chemically stained section differed from the HE-stained section,
the closest approximation was photographed. All selections were
controlled by an experienced pathologist (BR).
Immunostained blood vessels (by vWF and CD31) were counted
in accordance with pre-established criteria [17,18]. ‘Capillary
buds’ were defined as vessel structures without an identifiable
lumen or periendothelial structures, whereas all other stained
vessel structures were counted as ‘established blood vessels’. The
density of capillary buds and vessels were calculated per mm2. In
sections with more than 300 capillary buds per mm2, the numbers
were truncated to 300. Each photograph was counted manually
and one in ten randomly selected photographs were quality
controlled. Discrepancies were resolved by consensus, if necessary
after consulting a second senior pathologist. Finally, each
photograph was recounted.
Statistical analyses
The statistical analyses and sample size estimation were
performed with SPSS version 16.0 and PS Power and sample
size calculations version 2.1.31. Most variables were not normally
distributed and non-parametric tests were therefore used when
studying associations. Medians and interquartile ranges were used
to describe the results. The Mann-Whitney U and Kruskal-Wallis
H tests were applied where appropriate. For the calculation of
odds ratio (OR), it was necessary to tertilise the not normally
distributed variables. Spearman’s rank correlation coefficient was
used when studying associations between continuous variables.
Intra-observer variability was determined by calculating the intra-
class correlation coefficient (ICC) after log-transformation of the
data. A 5% significance level was used throughout.
Results
The median age of the Malawian patients was 23.5 years
(interquartile range (IQR)= 20.0–31.5), and the median age of the
Norwegian control patients was 44.0 years (IQR=30.5–55.5). In
the biopsies with S. haematobium ova, the median number of ova per
high-power field was 3 (IQR=1–8), of which 80 per cent were
calcified. Most ova were localised in the subepithelial tissue,
whereas only a few ova were found deeper in the stroma. Calcified
and viable ova were found together in the same biopsy in one
patient only. No schistosome worms were seen.
Figures 2 and 3A show the distributions of established blood
vessels and capillary buds respectively per mm2 genital tissue in the
four study groups. The periovular tissue contained significantly
Figure 2. Density of established blood vessels per mm2 in the four study groups. Established blood vessels stained with von Willebrand
Factor. FGS= cervicovaginal tissue with S. haematobium ova. aComparison of women with FGS and non-endemic women with normal cervical tissue.
doi:10.1371/journal.pntd.0001170.g002
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more established blood vessels compared with non-endemic
healthy cervices (p=0.017). However, ova viability was not
significantly associated with the density of established blood vessels
(p=0.40). There was no significant difference in the density of
established blood vessels between endemic biopsies with and
without S. haematobium ova (p=0.51).
As shown in Figure 3A, there were no significant differences in
the density of capillary buds between the Malawian cases and the
non-endemic or endemic negative controls (p=0.44 and p=0.95
respectively). However, there was a large variation in periovular
capillary bud density. As shown in Figure 3B, there was a tendency
towards a higher density of capillary buds surrounding viable ova
compared with non-endemic healthy cervical tissue (OR=13.0,
Confidence Interval (CI) = 1.0–172.9, p=0.052). Furthermore,
viable ova were more often found in granulation tissue compared
to calcified ova (p=0.032). There was no association between
calcified ova and fibrous tissue (p=0.53). The main histopatho-
logical periovular tissue reactions are shown in Figures S1 and S2.
In the endemic cases with cervicovaginal S. haematobium ova, age
was neither associated with the number of ova (p=0.45) nor the
viability status of the ova (p=0.50). There was no significant
difference in density of established blood vessels or capillary buds
between tissue with viable ova and non-endemic tissue with
chronic cervicitis (p=0.20 and p=0.053 respectively). All other
study groups had significantly lower densities of established blood
vessels and capillary buds than tissue with chronic cervicitis (data
not shown).
The intra-observer reliability of counting established blood
vessels and capillary buds were 0.93 (95% Confidence Interval
(CI) = 0.90–0.95, p,0.001) and 0.88 (95% CI= 0.82–0.91,
p,0.001), respectively.
Discussion
To our knowledge, this is the first study to analyse the quantity
and characteristics of the mucosal vasculature surrounding female
genital S. haematobium ova. Similar to non-specific chronic
cervicitis, the mucosa of the Malawian women diagnosed with
genital schistosomiasis was significantly more vascularised than
healthy cervical tissue of non-endemic controls. The denser
vasculature consisted of established blood vessels as opposed to
currently active neovascularisation. However, cases with viable
ova contained granulation tissue rich in sprouting blood vessels
significantly more often than cases with calcified ova.
Similar to previous reports of genital and urinary schistosomi-
asis, we found a variety of tissue reactions surrounding S.
haematobium ova; ranging from marked periovular granulation
tissue to fibrosis [14–16,19–25]. Although fibrosis is regarded as
the end-stage pathology in schistosome infected tissue [26], there
was no significant association between calcified ova and fibrosis in
our study.
This study has several limitations. Firstly, the sample size is
small and the findings are prone to type 1 and 2 errors. Secondly,
there may have been schistosome ova just outside the biopsy
borders in presumed negative cases, which might explain why
there was no significant difference in capillary density between
endemic cases and controls in this study. As in most schistosomiasis
studies, there was no true schistosomiasis negative endemic control
group [27]. The differences between women with and without
genital S. haematobium ova may therefore have been underestimat-
ed. Thirdly, the analyses may have been affected by the age of the
endemic biopsies, and by endothelial cell activation or vWF which
may be elevated in HIV positive individuals [28]. The HIV
prevalence has subsequently been estimated to be approximately
10 per cent of the population in 1994 [2], but individual HIV
diagnosis was not a part of the original project and could therefore
not be done. Lastly, although the specimens were evaluated several
times by two investigators who attempted to be objective, blinding
was not possible due to the presence of schistosome ova in the
tissue.
Previous studies on blood vessel proliferation and schistosomi-
asis have suggested that soluble egg antigens (SEA) from viable S.
mansoni ova induce neovascularisation by stimulating endothelial
cell activation and proliferation [10,11]. Recent experimental
studies indicate that blood vessel proliferation in S. mansoni not only
accompanies hepatic fibrogenesis, but possibly also regression of
fibrosis after treatment [29]. To our knowledge, there have been
no studies on S. haematobium and blood vessel proliferation.
Female genital schistosomiasis is associated with genital mucosal
bleeding tendency; a clinical finding that might support the
suggested HIV susceptibility in these women [30]. Endothelial cell
surface proteoglycans have been reported to serve as HIV-1
receptors, and endothelial cells have even been suggested to
harbour HIV [31–34]. Finally, an increase in microvessel density
may impair the original tissue structure and lead to easy disruption
of the genital mucosal barrier [35,36].
Women living in endemic areas are prone to high burdens of
infection and frequent reinfections with S. haematobium [37]. The
histopathological correlates of the clinical signs in female genital
schistosomiasis, e.g. abnormal blood vessel proliferation and
contact bleeding, have not yet been studied in detail [38]. It is
therefore not known which clinical manifestations may increase
the risk of reproductive tract morbidity or possibly HIV
acquisition. Hence it is not yet possible to give clinical advice
related to the risks and consequences of the typical lesions in
female genital schistosomiasis. In order to determine the
implications for the patients, further studies are needed to
correlate the clinical signs to morphological and immunohisto-
chemical findings.
In conclusion, this study shows that female genital mucosa
infected with S. haematobium is significantly more vascularised than
healthy cervical tissue. Viable schistosome ova are more often
surrounded by highly vascularised granulation tissue compared
with calcified ova. These results might contribute to improve the
understanding of the pathophysiological mechanisms in female
genital schistosomiasis and of the postulated association with HIV
infection. However, further studies are needed to validate these
findings, to study the immunological tissue reaction and to explore
the clinical correlates of the various histopathological manifesta-
tions in female genital schistosomiasis.
Supporting Information
Figure S1 Section of uterine cervix with calcified S.
haematobium ova. A. Histopathology Calcified schistosome
ova (white arrows) with periovular collagenised fibrous tissue (long,
Figure 3. Density of capillary buds. A. Density of capillary buds per mm2 in the four study groups. Capillary buds stained with CD31;
counts were truncated at 300 buds per mm2 for technical reasons. All non-endemic women with chronic cervicitis had capillary bud densities above
300 per mm2. FGS= cervicovaginal tissue with S. haematobium ova. aComparison of women with FGS and non-endemic women with normal cervical
tissue. B. Density of capillary buds per mm2 tissue with viable versus calcified ova.
doi:10.1371/journal.pntd.0001170.g003
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thin black arrows), scant mature fibroblasts (short, thin black
arrows) and established blood vessels (thick black arrow).
Haematoxylin and eosin (HE), 406 objective magnification. B.
Immunohistochemical detection of established mucosal
blood vessels Calcified schistosome ova (white arrows) with
periovular established blood vessels (black arrows). von Willebrand
Factor, 406 objective magnification.
(TIF)
Figure S2 Section of vagina with viable S. haematobium
ova. A. Histopathology Viable schistosome ova and shell
fragments (white arrows) surrounded by giant cells (long, thin
black arrows), granulation tissue, i.e. endothelial cell proliferation
and activation (E) and proliferation of immature fibroblasts (short,
thin black arrows), and inflammation with marked eosinophilia
(Eos). A tissue artifact (Art) traverses the lower half of the image.
Haematoxylin and eosin (HE), 406 objective magnification. B.
Immunohistochemical detection of mucosal blood vessel
budding Viable schistosome ova (white arrows) with abundant
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